NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) — Cash Flow Reinvestment Rate
NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) has a Cash Flow Reinvestment Rate of 0.00x as of December 2022, reinvesting $109.43K (capex $109.43K ) from operating cash flow of $29.19 Million. Explore reinvestment intensity of NewAmsterdam Pharma Company N.V. Ordinar to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
NewAmsterdam Pharma Company N.V. Ordinary Shares Cash Flow Reinvestment Rate (2022–2022)
Historical reinvestment intensity for NewAmsterdam Pharma Company N.V. Ordinary Shares across 1 annual periods. Also explore NAMS current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for NewAmsterdam Pharma Company N.V. Ordinary Shares (2022–2022)
Year-by-year capital reinvestment analysis for NewAmsterdam Pharma Company N.V. Ordinary Shares. For live market cap and broader valuation context, see market cap of NewAmsterdam Pharma Company N.V. Ordinar.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.09x | $936.00K | $10.66 Million | $221.00K | — |